New Duke study could mean fewer with early-stage breast cancer would face surgery, radiation
The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage zero breast cancer.
According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal ...
The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...
Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...
A study presented at SABCS 2024 reveals that active monitoring provides similar quality-of-life outcomes as surgery for patients with low-risk DCIS.
Women report having similar quality of life whether randomized to active monitoring or surgery for low-risk ductal carcinoma ...
For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...
DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.
An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback